News
-
Alliance
C4U and Sumitomo Pharma enter into License Agreement
-
IP
The Patent Issued in Europe
-
IP
The Patent Issued in Japan
-
IP
The Patent Issued in Japan
-
Alliance
C4U and Celaid Therapeutics have executed a collaborative research agreement for a hematopoietic stem cell gene therapy product.
-
IP
The patent for the invention, “METHOD FOR MANUFACTURING DNA-EDITED EUKARYOTIC CELL, AND KIT USED IN METHOD,” was issued by the China National Intellectual Property Administration (CNIPA) on November 17, 2023.Patent number is 110770342.
-
Alliance
C4U and The Center for Aquaculture Technologies (CAT) have entered into a collaborative research agreement to explore the application of CRISPR-Cas3 technology in the field of aquaculture.
-
IP
The patent for the invention, “METHOD FOR PRODUCING DNA-EDITED EUKARYOTIC CELL, AND KIT USED IN SAME,” was issued by the United States Patent and Trademark Office on November 7, 2023.Patent number is 11807869.
-
Alliance
C4U and Healiva have entered into a Strategic Alliance Agreement for medical applications of CRISPR-Cas3 technology.
-
Alliance
C4U enters into Non-Exclusive Sublicense Agreement with Rege Nephro